Kerry L. Spillane

Dana-Farber Cancer Institute

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Andrew R. Conery

Constellation Pharmaceuticals (United States)

Barbara M. Bryant

Constellation Pharmaceuticals (United States)

Jennifer A. Mertz

Constellation Pharmaceuticals (United States)

Richard C. Centore

Foghorn Therapeutics (United States)

Robert J. Sims

The University of Texas at Austin

Archana Bommi‐Reddy

Constellation Pharmaceuticals (United States)

Nicole E. Follmer

Merck & Co., Inc., Rahway, NJ, USA (United States)

Charlie Hatton

Dana-Farber Cancer Institute

Cyril H. Benes

Massachusetts General Hospital

Arnaud Amzallag

Bristol-Myers Squibb (United States)

Cooperative Institutions

Constellation Pharmaceuticals (United States)

Harvard University

Genentech

Morpho (United States)

Dana-Farber Cancer Institute

Massachusetts General Hospital

WuXi AppTec (China)

Howard Hughes Medical Institute

Roche (United States)

Foghorn Therapeutics (United States)

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Supplementary Materials and Methods from Preclinical Anticancer Efficacy of BET Bromodomain Inhibitors Is Determined by the Apoptotic Response

Andrew R. Conery Richard C. Centore Kerry L. Spillane Nicole E. Follmer Archana Bommi‐Reddy

This file contains additional information regarding the methods used in the manuscript, including shRNA sequences, peptide and antibody information, and details about analysis methods.

10.1158/0008-5472.22409204

Cite

Citations (0)

Cell line information from Preclinical Anticancer Efficacy of BET Bromodomain Inhibitors Is Determined by the Apoptotic Response

Andrew R. Conery Richard C. Centore Kerry L. Spillane Nicole E. Follmer Archana Bommi‐Reddy

This file contains the source of all cell lines used for the work described in the manuscript as well as the methods by which cell lines are authenticated at the repositories.

10.1158/0008-5472.22409207

Cite

Citations (0)

Supplementary Materials and Methods from Preclinical Anticancer Efficacy of BET Bromodomain Inhibitors Is Determined by the Apoptotic Response

Andrew R. Conery Richard C. Centore Kerry L. Spillane Nicole E. Follmer Archana Bommi‐Reddy

This file contains additional information regarding the methods used in the manuscript, including shRNA sequences, peptide and antibody information, and details about analysis methods.

10.1158/0008-5472.22409204.v1

Cite

Citations (0)

Supplementary figure legends from Preclinical Anticancer Efficacy of BET Bromodomain Inhibitors Is Determined by the Apoptotic Response

Andrew R. Conery Richard C. Centore Kerry L. Spillane Nicole E. Follmer Archana Bommi‐Reddy

This file contains the legends for the six supplementary figures.

10.1158/0008-5472.22409201.v1

Cite

Citations (0)

Supporting data Fig 4A from Preclinical Anticancer Efficacy of BET Bromodomain Inhibitors Is Determined by the Apoptotic Response

Andrew R. Conery Richard C. Centore Kerry L. Spillane Nicole E. Follmer Archana Bommi‐Reddy

This file contains source data for the graph in Figure 4A (GI50 and expression values for each of the genes in 245 cell lines).

10.1158/0008-5472.22409186

Cite

Citations (0)